Opportunity Information: Apply for PA 08 156
Apply for PA 08 156
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Biomarkers of Infection Associated Cancers (R01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.121 Oral Diseases and Disorders Research 93.393 Cancer Cause and Prevention Research 93.394 Cancer Detection and Diagnosis Research 93.396 Cancer Biology Research.
- This funding opportunity was created on Dec 5, 2008 and posted on Apr 22, 2008.
- Applicants must submit their applications by May 7, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Public and State controlled institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) For profit organizations other than small businesses State governments Private institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education.
- Other Eligible Applicants include the following Eligible Agencies of the Federal Government Hispanic serving Institutions Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Biomarkers of Infection Associated Cancers (R01) opportunity (Funding Opportunity Number PA-08-156) is a National Institutes of Health (NIH) funding announcement led by the National Cancer Institute (NCI) with participation from the National Institute of Dental and Craniofacial Research (NIDCR). Its central goal is to support research projects that identify and develop biomarkers for cancers in which infectious agents play a causal role in disease development. In practical terms, the grant is aimed at helping researchers find measurable biological indicators tied to infection-driven cancers, such as markers that could improve cancer risk prediction, enable earlier detection, support diagnosis, clarify prognosis, or track disease progression and response to therapy in settings where infection is part of the underlying etiology.
This announcement uses the standard NIH Research Project Grant (R01) mechanism, which is generally intended for more mature, hypothesis-driven projects with a defined research plan and a scope that can be sustained over multiple years. The FOA also notes that it runs in parallel with a separate but scientifically identical announcement using the R21 mechanism (PA-08-157). That parallel track matters because it signals NIH is supporting both exploratory early-stage biomarker work (R21) and more fully developed, comprehensive research programs (R01) in the same scientific space, allowing applicants to choose a mechanism that matches the maturity and scale of their proposed work.
The funding category is listed as discretionary, and awards are described as contingent on both the availability of funds and the receipt of a sufficient number of highly meritorious applications. In other words, there is no guaranteed number of awards, and applications compete based on scientific merit and program priorities during the relevant cycles. The activity areas associated with the announcement span cancer cause and prevention, cancer detection and diagnosis, cancer biology, and oral diseases and disorders research, reflecting the involvement of both NCI and NIDCR and the broad relevance of infection-related carcinogenesis across organ systems, including the oral and craniofacial domain.
Eligibility is broad and includes many common NIH applicant types: public and state-controlled institutions of higher education, private institutions of higher education, for-profit organizations (other than small businesses), small businesses, state governments, and nonprofit organizations with or without 501(c)(3) status (with distinctions depending on whether they are institutions of higher education). The FOA also explicitly includes additional eligible applicants such as certain federal agencies, Hispanic-serving institutions, U.S. territories and possessions, regional organizations, and non-U.S. entities (foreign organizations). This broad eligibility framework is consistent with NIH’s interest in supporting biomarker discovery and validation efforts that may require diverse clinical populations, global infectious disease contexts, and specialized laboratory capabilities.
Administratively, the opportunity was posted on April 22, 2008, and ultimately closed on May 7, 2011, with an archive date of June 7, 2011, meaning it is no longer open for new applications but remains as a reference record. There is no cost sharing or matching requirement. The primary agency contact listed for access or linking issues is the NIH Office of Extramural Research (OER) webmaster, and the official full text of the announcement was hosted through the NIH grants guide page referenced in the additional information link.
Frequently Asked Questions (FAQs): Biomarkers of Infection Associated Cancers (R01) - PA-08-156
What is the Biomarkers of Infection Associated Cancers (R01) opportunity (PA-08-156)?
PA-08-156 is a National Institutes of Health (NIH) funding opportunity announcement focused on research to identify and develop biomarkers for cancers where an infectious agent plays a causal role in disease development. It uses the NIH Research Project Grant (R01) mechanism and is led by the National Cancer Institute (NCI), with participation from the National Institute of Dental and Craniofacial Research (NIDCR).
What is the main goal of this funding announcement?
The central goal is to support research projects that discover and advance measurable biological indicators (biomarkers) related to infection-driven cancers. These biomarkers are intended to improve understanding and management of cancers that arise, in part, due to infection-related causes.
What kinds of biomarkers and outcomes does the FOA emphasize?
Based on the description provided, biomarkers under this FOA could be used to improve cancer risk prediction, enable earlier detection, support diagnosis, clarify prognosis, and track disease progression and response to therapy in situations where infection contributes to the underlying etiology.
Which NIH grant mechanism does PA-08-156 use?
This announcement uses the standard NIH Research Project Grant (R01) mechanism, which is generally aligned with more mature, hypothesis-driven projects that have a defined research plan and a scope that can be sustained over multiple years.
How does this R01 opportunity relate to the R21 announcement mentioned (PA-08-157)?
PA-08-156 runs in parallel with PA-08-157, a separate announcement that is scientifically identical but uses the R21 mechanism. The parallel structure indicates NIH support for both exploratory early-stage biomarker work (R21) and more fully developed, comprehensive research programs (R01), allowing applicants to choose the mechanism that best fits the maturity and scale of their proposed work.
Which NIH institutes are involved?
The opportunity is led by the National Cancer Institute (NCI) with participation from the National Institute of Dental and Craniofacial Research (NIDCR). The involvement of both institutes reflects the relevance of infection-related carcinogenesis across organ systems, including the oral and craniofacial domain.
What scientific or activity areas does this FOA cover?
The activity areas listed for this opportunity span cancer cause and prevention, cancer detection and diagnosis, cancer biology, and oral diseases and disorders research.
Is the funding guaranteed, and how are awards determined?
No specific number of awards is guaranteed. The announcement describes the funding category as discretionary, and awards are contingent on the availability of funds and the receipt of a sufficient number of highly meritorious applications. Applications compete based on scientific merit and program priorities during the relevant cycles.
Who is eligible to apply?
Eligibility is broad and includes public and state-controlled institutions of higher education, private institutions of higher education, for-profit organizations (other than small businesses), small businesses, state governments, and nonprofit organizations with or without 501(c)(3) status (with distinctions depending on whether they are institutions of higher education).
Are non-U.S. (foreign) organizations eligible?
Yes. The FOA explicitly includes non-U.S. entities (foreign organizations) among eligible applicants.
Are any special institution types explicitly included?
Yes. The FOA explicitly includes certain federal agencies, Hispanic-serving institutions, U.S. territories and possessions, and regional organizations, in addition to the more common NIH applicant types.
Is there a cost sharing or matching requirement?
No. The announcement states there is no cost sharing or matching requirement.
When was the opportunity posted, and is it still open?
The opportunity was posted on April 22, 2008. It ultimately closed on May 7, 2011, and has an archive date of June 7, 2011. This means it is no longer open for new applications, but remains available as a reference record.
Where was the official full text hosted?
The official full text of the announcement was hosted through the NIH grants guide page referenced in the additional information link described in the opportunity record.
Who is the contact for access or linking issues?
The primary agency contact listed for access or linking issues is the NIH Office of Extramural Research (OER) webmaster.
Does the FOA indicate why such broad eligibility might be important for this topic?
Yes, the description notes that broad eligibility is consistent with NIH interest in supporting biomarker discovery and validation efforts that may require diverse clinical populations, global infectious disease contexts, and specialized laboratory capabilities.
Browse more opportunities from the same category: Education Health
Next opportunity: Biomarkers of Infection Associated Cancers (R21)
Previous opportunity: Science Education Drug Abuse Partnership Award R25
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 08 156
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 08 156) also looked into and applied for these:
| Funding Opportunity |
|---|
| Biomarkers of Infection Associated Cancers (R21) Apply for PA 08 157 Funding Number: PA 08 157 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Transdisciplinary Research on Fatigue and Fatigability in Aging (R01) Apply for PA 08 161 Funding Number: PA 08 161 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Transdisciplinary Research on Fatigue and Fatigability in Aging (R21) Apply for PA 08 162 Funding Number: PA 08 162 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Stem Cells and Cancer (R21) Apply for PA 08 165 Funding Number: PA 08 165 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Economics of Treatment and Prevention Services for Drug Alcohol Abuse (R03) Apply for PA 08 172 Funding Number: PA 08 172 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Economics of Treatment and Prevention Services for Drug Alcohol Abuse (R01) Apply for PA 08 174 Funding Number: PA 08 174 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Novel Lentiviral Models of HIV Neuropathogenesis (R01) Apply for PAS 08 178 Funding Number: PAS 08 178 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Novel Lentiviral Models of HIV Neuropathogenesis (R21) Apply for PAS 08 179 Funding Number: PAS 08 179 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Exploratory/Developmental Grant for Complementary and Alternative Medicine (CAM) Studies using Cells, Tissues, and Animal Models of Disease (R21) Apply for PA 08 185 Funding Number: PA 08 185 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Medications Development for Polydrug Addiction Treatment (R01) Apply for PAS 08 186 Funding Number: PAS 08 186 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Medications Development for Polydrug Addiction Treatment (R21) Apply for PAS 08 187 Funding Number: PAS 08 187 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Integrating Biobehavioral and Sociocultural Research to Prevent HIV Transmission and Infection (R01) Apply for PA 08 188 Funding Number: PA 08 188 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Integrating Biobehavioral and Sociocultural Research to Prevent HIV Transmission and Infection (R21) Apply for PA 08 189 Funding Number: PA 08 189 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Geographic and Contextual Influences on Energy Balance Related Health Behaviors (R01) Apply for PA 08 192 Funding Number: PA 08 192 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Geographic and Contextual Influences on Energy Balance Related Health Behaviors (R21) Apply for PA 08 193 Funding Number: PA 08 193 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Technological Innovations for Interdisciplinary Research Incorporating the Behavioral and Social Sciences (STTR R41/R42) Apply for PAR 08 201 Funding Number: PAR 08 201 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Pilot studies in Pancreatic Cancer (R21) Apply for PA 08 208 Funding Number: PA 08 208 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| PPilot studies in Pancreatic Cancer (R03) Apply for PA 08 209 Funding Number: PA 08 209 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Diet Induced Changes in Inflammation as Determinants of Colon Cancer (R01) Apply for PA 08 210 Funding Number: PA 08 210 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Diet Induced Changes in Inflammation as Determinants of Colon Cancer (R21) Apply for PA 08 211 Funding Number: PA 08 211 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 08 156", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
